Enter any phrase or word you would like to search for and click .
PostNews: Interim Report
![Banner image showing gloved hand holding a cell flask.](https://phiab.com/wp-content/uploads/2023/03/cell-flask-banner-320x180.jpg)
Interim Report 3 2022/23
Sales have continued to grow, with significantly higher cost efficiency. As a result, rolling 12-month sales gained to its highest level ever.
Learn more …
PostNews: Press Release
Clarification Regarding Potential Collaborations
Thi information is provided to mitigate any misinterpretation of the information unintentionally made publicly after a PHI presentation at a CERN Knowledge Transfer Seminar held on March 27, 2023.
Learn more …
PostNews: Press Release
Notice that Interim Report 3 2022/23 will be published already on March 28, 2023
PHI changes the date for publication of Interim Report 3 2022/23 to March 28, 2023.
Learn more …
PostNews: Press Release
![Artistic image of molecularly imprinted polymers (MIP).](https://phiab.com/wp-content/uploads/2020/08/Molecularly-Imprinted-Polymers-MIP-320x180.jpg)
PHI creates a subsidiary for the anticipated EU patent concerning synthetic antibodies
PHI has decided to create a dedicated subsidiary to house the synthetic antibody patent family and facilitate its business potential.
Learn more …
PostBlog Post
![KT-seminar-The_Promise_of_Regenerqtion_Medicine_and_AI-Fb_bannernew](https://phiab.com/wp-content/uploads/2023/03/KT-seminar-The_Promise_of_Regenerqtion_Medicine_and_AI-Fb_bannernew-320x180.png)
CERN seminar: The Promise of Regenerative Medicine and AI
During this seminar, Peter Egelberg, Founder of PHI, will present the work carried out by PHI in the development of time-lapse cytometry instrumentation and software.
Learn more …
PostNews
![Swiss-based Altium major investor BioStock](https://phiab.com/wp-content/uploads/2023/03/Suisse_PHI-320x180.jpg)
BioStock: PHI catches eye of major investor
BioStock contacted Altium’s CEO Goran Dubravcic to learn more about their incentives to invest in PHI.
Learn more …